INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,525 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$146K
950 sh
Jan 8, 2026
Page 1511 of 1814
← PrevNext →
Jan 9, 2026
traded Jan 8, 2026
+1d
SEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$212K
1,417 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

6
RM
Reaume Marty MDirector
SPSCSPS COMMERCE INC
Option exercise · 10b5-1 plan
M$90K
1,732 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

5
ZC
Zedelmayer ChristineSr. Vice President and COO
EQEquillium, Inc.
Grant or award
A—
500.0K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

5
CJ
Carroll Hugh JDirector
TXRHTexas Roadhouse, Inc.
Grant or award
A—
1,200 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

5
Cook Scott DDirector
INTUINTUIT INC.
Gift
G—
30.8K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

5
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$9,983
88 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

5
RM
Reaume Marty MDirector
SPSCSPS COMMERCE INC
Open-market sale · 10b5-1 plan
SELL$37K
400 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$773K
45.0K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

4
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$103K
2,456 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$16K
100 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$39K
250 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$16K
100 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

3
WA
Williams Laura AChief Patient Officer
ARDXARDELYX, INC.
Option exercise · 10b5-1 plan
M$50K
50.0K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$16K
100 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$39K
250 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

3
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M$221K
27.9K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$15K
100 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

3
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$31K
196 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$15K
100 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$16K
100 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

1
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$53K
2,500 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

1
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$53K
2,500 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

1
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$262K
25.2K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
55.6K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M—
3,320 sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M—
27.9K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
55.6K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Disposition to issuer · 10b5-1 plan
D—
47.2K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
2,626 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
25.2K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$39K
202 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
55.6K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
47.2K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Disposition to issuer · 10b5-1 plan
D—
55.6K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M$26K
3,320 sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
47.2K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
3,458 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

0
WA
Williams Laura AChief Patient Officer
ARDXARDELYX, INC.
Option exercise · 10b5-1 plan
M—
0 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

0
TP
Tom PennyPrincipal Accounting Officer
EQEquillium, Inc.
Grant or award · 10b5-1 plan
A—
450.0K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence